Kalvista Pharmaceuticals Inc (KALV) Stock Analysis
Verdict: HOLD
High-conviction HAE commercialization story meets extreme technical overextension and aggressive insider selling at 52-week highs.
Investment score: 64/100
Analysis as of
Is Kalvista Pharmaceuticals Inc stock worth reviewing? The TradeMates thesis
KalVista is at a critical juncture transitioning to a commercial enterprise with sebetralstat. Financials show a healthy $229M cash pile, but negative equity and heavy 30-day gains suggest a 'pullback entry' is more prudent than chasing the current peak.
7-factor investment score
- Valuation: 50/100 (weight 20%)
- Financial Health: 45/100 (weight 15%)
- Technical Momentum: 85/100 (weight 15%)
- Earnings Quality: 80/100 (weight 15%)
- Insider Sentiment: 20/100 (weight 10%)
- Analyst Consensus: 75/100 (weight 10%)
- Risk-Adjusted Return: 60/100 (weight 15%)
Kalvista Pharmaceuticals Inc opportunities and risks
What speaks for KALV
- Oral delivery advantage in HAE market
What speaks against KALV
- Regulatory Approval Binary Risk
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| KALV | n/a | 12.3x | n/a | 92.0% | -119.4% | -1.7% |
| BHVN | n/a | 0.0x | n/a | 0.0% | 0.0% | -55.8% |
| PGEN | n/a | 40.3x | n/a | 75.6% | -647.0% | -9.2% |
| SLS | n/a | 0.0x | n/a | 0.0% | 0.0% | -2.4% |
| BCAX | n/a | 0.0x | n/a | 0.0% | 0.0% | -9.7% |
| VIR | n/a | 24.2x | n/a | 275.2% | -676.0% | -28.1% |
| Peer median | n/a | 0.0x | n/a | 0.0% | 0.0% | -9.7% |
Frequently asked questions about Kalvista Pharmaceuticals Inc (KALV)
Is KALV stock a good investment?
The TradeMates model rates Kalvista Pharmaceuticals Inc as HOLD with an investment score of 64/100. KalVista is at a critical juncture transitioning to a commercial enterprise with sebetralstat. Financials show a healthy $229M cash pile, but negative equity and heavy 30-day gains suggest a 'pullback entry' is more prudent than chasing the current peak. This is algorithmic model output, not personal investment advice.
Is KALV stock a buy?
The TradeMates model verdict for KALV is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.